Follicular T-helper cell recruitment governed by bystander B cells and ICOS-driven motility H Xu, X Li, D Liu, J Li, X Zhang, X Chen, S Hou, L Peng, C Xu, W Liu, ... Nature 496 (7446), 523-527, 2013 | 446 | 2013 |
Transcription factor achaete-scute homologue 2 initiates follicular T-helper-cell development X Liu, X Chen, B Zhong, A Wang, X Wang, F Chu, RI Nurieva, X Yan, ... Nature 507 (7493), 513-518, 2014 | 359 | 2014 |
FcγR-binding is an important functional attribute for immune checkpoint antibodies in cancer immunotherapy X Chen, X Song, K Li, T Zhang Frontiers in immunology 10, 439909, 2019 | 144 | 2019 |
An efficient one‐pot four‐segment condensation method for protein chemical synthesis S Tang, YY Si, ZP Wang, KR Mei, X Chen, JY Cheng, JS Zheng, L Liu Angewandte Chemie International Edition 54 (19), 5713-5717, 2015 | 141 | 2015 |
A GPR174–CCL21 module imparts sexual dimorphism to humoral immunity R Zhao, X Chen, W Ma, J Zhang, J Guo, X Zhong, J Yao, J Sun, ... Nature 577 (7790), 416-420, 2020 | 75 | 2020 |
Phenotypic Tfh development promoted by CXCR5-controlled re-localization and IL-6 from radiation-resistant cells X Chen, W Ma, T Zhang, L Wu, H Qi Protein & cell 6 (11), 825-832, 2015 | 49 | 2015 |
Chemical synthesis of a two-photon-activatable chemokine and photon-guided lymphocyte migration in vivo X Chen, S Tang, JS Zheng, R Zhao, ZP Wang, W Shao, HN Chang, ... Nature communications 6 (1), 7220, 2015 | 43 | 2015 |
Neuronal, stromal, and T-regulatory cell crosstalk in murine skeletal muscle K Wang, OK Yaghi, RG Spallanzani, X Chen, D Zemmour, N Lai, IM Chiu, ... Proceedings of the National Academy of Sciences 117 (10), 5402-5408, 2020 | 36 | 2020 |
Follicular T‐helper cells: controlled localization and cellular interactions H Qi, X Chen, C Chu, P Lu, H Xu, J Yan Immunology and Cell Biology 92 (1), 28-33, 2014 | 36 | 2014 |
Total chemical synthesis of photoactivatable proteins for light-controlled manipulation of antigen–antibody interactions S Tang, Z Wan, Y Gao, JS Zheng, J Wang, YY Si, X Chen, H Qi, L Liu, ... Chemical Science 7 (3), 1891-1895, 2016 | 30 | 2016 |
An Fc-competent anti-human TIGIT blocking antibody ociperlimab (BGB-A1217) elicits strong immune responses and potent anti-tumor efficacy in pre-clinical models X Chen, L Xue, X Ding, J Zhang, L Jiang, S Liu, H Hou, B Jiang, L Cheng, ... Frontiers in Immunology 13, 828319, 2022 | 27 | 2022 |
A new method for synthesis of peptide thioesters via irreversible N-to-S acyl transfer JS Zheng, X Chen, S Tang, HN Chang, FL Wang, C Zuo Organic letters 16 (18), 4908-4911, 2014 | 21 | 2014 |
Tfh cell differentiation and their function in promoting B-cell responses H Qi, X Chen, C Chu, D Liu, W Ma, Y Wang, L Wu, H Yan, J Yan T Helper Cell Differentiation and Their Function, 153-180, 2014 | 20 | 2014 |
Nuclear receptors of the NR4a family are not required for the development and function of follicular T helper cells W Ma, R Zhao, R Yang, B Liu, X Chen, L Wu, H Qi International immunopharmacology 28 (2), 841-845, 2015 | 9 | 2015 |
A new and robust method of tethering IgG surrogate antigens on lipid bilayer membranes to facilitate the TIRFM based live cell and single molecule imaging experiments S Zhang, L Xu, X Zhao, X Chen, Y Fan, Z Wan, Y Xu, W Liu PloS one 8 (5), e63735, 2013 | 7 | 2013 |
Natural killer cells: the next wave in cancer immunotherapy X Chen, L Jiang, X Liu Frontiers in immunology 13, 954804, 2022 | 6 | 2022 |
A Fc-competent anti-human TIGIT blocking antibody BGB-A1217 elicits strong immune responses and potent anti-tumor efficacy in pre-clinical models X Chen, L Xue, X Ding, Q Liu, J Zhang, L Jiang, S Liu, H Hou, Q Zhu, ... J Cancer Res 81 (suppl 13), 1854, 2021 | 6 | 2021 |
Deciphering the microbiome-immunity-cancer axis X Chen, C Jin, A Facciabene, X Guo, Y Zhang Frontiers in Immunology 13, 897811, 2022 | 2 | 2022 |
Structural insights into the unique pH-responsive characteristics of the anti-TIGIT therapeutic antibody Ociperlimab J Sun, X Zhang, L Xue, L Cheng, J Zhang, X Chen, Z Shen, K Li, L Wang, ... Structure 32 (5), 550-561. e5, 2024 | | 2024 |
BGB-A445, a novel non-ligand-blocking agonistic anti-OX40 antibody, exhibits superior immune activation and antitumor effects in preclinical models B Jiang, T Zhang, M Deng, W Jin, Y Hong, X Chen, X Chen, J Wang, ... Frontiers of Medicine, 1-16, 2023 | | 2023 |